Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Continuous Monitoring of Blood Pressure in Spontaneous Intraparenchimal Cerebral Haemorrhage (BP-MONICH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01956292
Recruitment Status : Unknown
Verified October 2013 by Simone Vidale, Azienda Ospedaliera Sant'Anna.
Recruitment status was:  Not yet recruiting
First Posted : October 8, 2013
Last Update Posted : October 8, 2013
Sponsor:
Information provided by (Responsible Party):
Simone Vidale, Azienda Ospedaliera Sant'Anna

Tracking Information
First Submitted Date September 29, 2013
First Posted Date October 8, 2013
Last Update Posted Date October 8, 2013
Study Start Date October 2013
Estimated Primary Completion Date October 2014   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: October 5, 2013)
evaluation of blood pressure varibility on clinical course in patients with cerebral haemorrhage [ Time Frame: Day 7 ]
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Continuous Monitoring of Blood Pressure in Spontaneous Intraparenchimal Cerebral Haemorrhage
Official Title Observational Study of Continous Monitoring of Arterial Blood Pressure in Spontaneous Intraparenchimal Cerebral Haemorrhage
Brief Summary Evaluation of blood pressure variability in the acute phase of intraparenchimal cerebral haemorrhage and its consequences to clinical outcome
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population Patients admitted to hospital for intraparenchimal cerebral haemorrhage
Condition Intraparenchimal Cerebral Haemorrhage
Intervention Not Provided
Study Groups/Cohorts Intraparenchimal cerebral haemorrhage
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: October 5, 2013)
100
Original Estimated Enrollment Same as current
Estimated Study Completion Date June 2015
Estimated Primary Completion Date October 2014   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • hospitalization only for spontaneous intraparenchimal cerebral haemorrhage
  • age over 18 years

Exclusion Criteria:

  • cerebral haemorrhage secondary to other causes
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Italy
Removed Location Countries  
 
Administrative Information
NCT Number NCT01956292
Other Study ID Numbers OSA-0002
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Simone Vidale, Azienda Ospedaliera Sant'Anna
Study Sponsor Azienda Ospedaliera Sant'Anna
Collaborators Not Provided
Investigators Not Provided
PRS Account Azienda Ospedaliera Sant'Anna
Verification Date October 2013